A multinational pharmaceutical company initiated a development partnership with a small US start-up to advance a portfolio of Class III medical devices based on a novel biomaterial.
As project manager for two years, I led a diverse, international team of experts and executives. Together we defined a project plan, design and development plan, design input, and initial ISO 14971 risk analysis.
We successfully conducted pre-clinical proof-of-concept studies, performed a gap analysis of manufacturing processes, and developed optimized formulations for further testing. Throughout the collaboration, I provided regular progress reports to the management board.
I am the Expert by your Side

-
- Aesthetic dermatology
- Medicinal plants & herbal medicines
- Biomaterials
- Medical devices
- Ophthalmology & orthopedics
- Reviewing non-clinical chapters for EU MDR documentation
- Preparing technical & scientific due diligence
Concept
From Idea to Strategy
Practical Solutions
Leadership & Collaboration
Scientific Expertise
Proven Track Record
Case Study I: Leading an International R&D Collaboration
Case Study II: Preparing for Technical & Scientific Due Diligence
A medium-sized European biomaterials company was entering negotiations with a larger international partner. Engaged as an expert in biomaterials and aesthetic dermatology, I reviewed the existing data and reports, performed a gap analysis, and advised on how to best present the information. I also recommended additional studies to strengthen the scientific package. My input provided the client’s business development team with a clear, credible foundation for discussions with the potential partner.
Case Study III: Achieving MDR Compliance for a Substance-Based Device
A medium-sized European company faced the risk of reclassification or loss of CE certification for a substance-based medical device under Regulation (EU) 2017/745 (MDR).
Consulted as an expert in medicinal plants, I collaborated with the client’s analytical team to investigate the composition and pharmacological activity of the herbal extract. I engaged with contract labs on suitable proof-of-concept studies and explored alternative preparation methods to meet regulatory requirements.
These insights equipped the project leader with a clear basis to plan the product’s MDR compliance strategy.
References
Dr. Michael Pfeil
“I had the opportunity to work with Charlotte on a highly challenging process transfer project from R&D to manufacturing. Charlotte proved profound knowledge of the scientific and technical background as well as collaborative and solution focused leadership skills. She is an expert in the field of hyaluronic acid-based hydrogels and an absolutely reliable partner for complex tasks who is able to keep a team motivated throughout the project.”
Stephen Makin, PhD
„[…]Dr. Reither established an extremely good relationship with her direct reports, peers and managers. She set clear directions for the group and rapidly established the priorities for the business […].
Dr. Andreas Rose
„Zusammen haben wir an diversen Projekten gearbeitet: – Sicherstellung der GMP Compliance im Entwicklungslabor – Erstellung einer Prozesslandkarte inkl. RACI-Matrix für Entwicklungsprojekte – Erstellung von SOPs/WIs im Bereich Design and Development von Medizinprodukten – Inspektionsvorbereitung , -durchführung und -nachbereitung Die Zusammenarbeit mit Charlotte war jederzeit sehr kollegial und von großer Wertschätzung sowie gegenseitigem Vertrauen geprägt.“
Dr. med. Rolf Bartsch
“Charlotte has a deep understanding of the science behind dermal fillers. It was a pleasure to work with her on highly innovative early development projects as well as product launches.”
Micki Lew
“Charlotte is a creative leader with strong technical background. I have worked with her on Class III medical devices for the US market including discussions with the FDA on non-clinical strategies that led to product approvals. Her thoughtful insight and solution-oriented approach focused the team on moving projects forward in a collaborative manner.”
David Ferrero, PhD
“…Charlotte is independent, detail-oriented, and deeply knowledgeable about the medical aesthetics market. A strong presenter and collaborator, she excels at driving projects forward, connecting the dots, and ensuring seamless execution. Her ability to align teams and deliver results makes her a tremendous asset to any organization. I highly recommend her for any role requiring strong leadership, project execution, and cross-functional collaboration.”
Dr. Alejandro Lopez Landa
“…Her organizational and technical skills and commitment to her projects are remarkable, making her ideal for complex Life Science projects.
Charlotte´s proactive attitude and problem-solving abilities make her someone you can always rely on. She manages resources, schedules, and team dynamics with efficiency and grace and her dedication to delivering high-quality results is truly inspiring.”
Cheri Mao
“Charlotte is everything one looks for in a partner and program manager. Her confidence and competence are rooted by her depth of experience. She is thoughtful, data-driven, solution-oriented, pragmatic, and open to alternative viewpoints. Aside from Charlotte’s professional qualifications, she is a warm person who truly wants to bring joy to her work and her colleagues. A rare gem.”
Dr. Elsa Locardi
“…Her program management skills are exceptional and her knowledge in new product development and injectable aesthetics field is very thorough. I really enjoyed working with Charlotte since she has always delivered on the tasks assigned to her, with clear communication and building strong relationships within the teams…”
Approach
Phase I – Orientation
Identify gaps
Define next steps
Phase II – Planning
Project & time plans
Regulatory strategy
Collaboration partners
Phase III – Execution
Interim management
Drive work packages
Meet milestones
Phase IV – Transfer & Maintenance
Knowledge transfer
Training & coaching
Ongoing advisory
01.
Phase I – Orientation
- Building a solid foundation by analyzing the current situation and identifying priorities.
- Reviewing existing data and information Identifying key topics and gaps
- Connecting with stakeholders, teams, and experts
- Conducting literature research
- Defining recommendations and next steps
Typical duration: 2 days to 3 months (approx. 16–200 hours)
02.
Phase II – Planning
- Translating insights into structured strategies and actionable plans.
- Developing project and time plans
- Refining key topics and recommendations
- Identifying collaboration partners
- Defining development and regulatory strategies
Typical duration: 1 week to 3 months (approx. 30–420 hours)
03.
Phase III – Execution
- Driving projects forward with leadership and focus.
- Leading as interim manager or project leader
- Executing work packages according to project plan
- Managing timelines and milestones
Typical duration: several months to 1 year or more, depending on complexity.
04.
Phase IV – Transfer & Maintenance
- Ensuring continuity and long-term success
- Knowledge and technical transfer
- Training and coaching
- Supporting teams and processes
- Providing ongoing scientific and technical advice
Duration depends on project scope and needs
About me
Let’s make progress happen.
Get in touch – I am the Expert by Your Side

